3aps (3-amino-1-propanesulfonic acid - aka : homotaurine) is being developed by Neurochem Pharmaceuticals for the treatment of Alzheimer's disease (Alzhemed) and for the treatment of hemorrhagic stroke due to cerebral amyloid angiopathy (Cerebril.) 3aps is a synthetic gamma-aminobutyric acid (GABA) analog that functions as an agonist at the GABA-A receptor and has been discovered to bind to amyloid beta.

provided by;

Alzheimer's Disease Education and Referral Center

NLM (Pubmed) search results for 'homotaurine' and '3aps'

Clinicaltrials.gov search results for 'homotaurine' and '3aps'

Neurochem Pharmaceuticals product pipeline

Big Pharmaceutical Companies - caveat emptor!